190 related articles for article (PubMed ID: 19122792)
1. Statistical learning of origin-specific statically optimal individualized treatment rules.
van der Laan MJ; Petersen ML
Int J Biostat; 2007; 3(1):Article 6. PubMed ID: 19122792
[TBL] [Abstract][Full Text] [Related]
2. Causal effect models for realistic individualized treatment and intention to treat rules.
van der Laan MJ; Petersen ML
Int J Biostat; 2007; 3(1):Article 3. PubMed ID: 19122793
[TBL] [Abstract][Full Text] [Related]
3. Individualized treatment rules: generating candidate clinical trials.
Petersen ML; Deeks SG; van der Laan MJ
Stat Med; 2007 Nov; 26(25):4578-601. PubMed ID: 17450501
[TBL] [Abstract][Full Text] [Related]
4. Marginal Structural Models with Counterfactual Effect Modifiers.
Zheng W; Luo Z; van der Laan MJ
Int J Biostat; 2018 Jun; 14(1):. PubMed ID: 29883322
[TBL] [Abstract][Full Text] [Related]
5. Targeted maximum likelihood based causal inference: Part I.
van der Laan MJ
Int J Biostat; 2010; 6(2):Article 2. PubMed ID: 21969992
[TBL] [Abstract][Full Text] [Related]
6. Doubly Robust and Efficient Estimation of Marginal Structural Models for the Hazard Function.
Zheng W; Petersen M; van der Laan MJ
Int J Biostat; 2016 May; 12(1):233-52. PubMed ID: 27227723
[TBL] [Abstract][Full Text] [Related]
7. Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.
Orellana L; Rotnitzky A; Robins JM
Int J Biostat; 2010; 6(2):Article 8. PubMed ID: 21969994
[TBL] [Abstract][Full Text] [Related]
8. Robust regression for optimal individualized treatment rules.
Xiao W; Zhang HH; Lu W
Stat Med; 2019 May; 38(11):2059-2073. PubMed ID: 30740747
[TBL] [Abstract][Full Text] [Related]
9. Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working Models.
Petersen M; Schwab J; Gruber S; Blaser N; Schomaker M; van der Laan M
J Causal Inference; 2014 Jun; 2(2):147-185. PubMed ID: 25909047
[TBL] [Abstract][Full Text] [Related]
10. Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.
Hogan JW; Lancaster T
Stat Methods Med Res; 2004 Feb; 13(1):17-48. PubMed ID: 14746439
[TBL] [Abstract][Full Text] [Related]
11. History-adjusted marginal structural models for estimating time-varying effect modification.
Petersen ML; Deeks SG; Martin JN; van der Laan MJ
Am J Epidemiol; 2007 Nov; 166(9):985-93. PubMed ID: 17875580
[TBL] [Abstract][Full Text] [Related]
12. Targeted maximum likelihood based causal inference: Part II.
van der Laan MJ
Int J Biostat; 2010; 6(2):Article 3. PubMed ID: 21731531
[TBL] [Abstract][Full Text] [Related]
13. Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules.
Butler EL; Laber EB; Davis SM; Kosorok MR
Biometrics; 2018 Mar; 74(1):18-26. PubMed ID: 28742260
[TBL] [Abstract][Full Text] [Related]
14. Analyzing sequentially randomized trials based on causal effect models for realistic individualized treatment rules.
Bembom O; van der Laan MJ
Stat Med; 2008 Aug; 27(19):3689-716. PubMed ID: 18407580
[TBL] [Abstract][Full Text] [Related]
15. Targeted minimum loss based estimator that outperforms a given estimator.
Gruber S; van der Laan MJ
Int J Biostat; 2012 May; 8(1):Article 11. PubMed ID: 22628356
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
[TBL] [Abstract][Full Text] [Related]
18. Bayesian analysis of complex interacting mutations in HIV drug resistance and cross-resistance.
Kozyryev I; Zhang J
Adv Exp Med Biol; 2015; 827():367-83. PubMed ID: 25387976
[TBL] [Abstract][Full Text] [Related]
19. Estimating individualized treatment rules in longitudinal studies with covariate-driven observation times.
Coulombe J; Moodie EE; Shortreed SM; Renoux C
Stat Methods Med Res; 2023 May; 32(5):868-884. PubMed ID: 36927216
[TBL] [Abstract][Full Text] [Related]
20. Targeted Learning of the Mean Outcome under an Optimal Dynamic Treatment Rule.
van der Laan MJ; Luedtke AR
J Causal Inference; 2015 Mar; 3(1):61-95. PubMed ID: 26236571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
